Cargando…

AWBAT(TM): Early Clinical Experience

Objective: The purpose of this article is to describe the early clinical experience with AWBAT. Methods: Burn patients requiring (1) donor sites or (2) treatment of a superficial burn wound injury were treated. A total of 45 patients with 69 distinct wounds were included. AWBAT(TM)-D was evaluated i...

Descripción completa

Detalles Bibliográficos
Autor principal: Vandenberg, Victoria B.
Formato: Texto
Lenguaje:English
Publicado: Open Science Company, LLC 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847823/
https://www.ncbi.nlm.nih.gov/pubmed/20361005
_version_ 1782179603706544128
author Vandenberg, Victoria B.
author_facet Vandenberg, Victoria B.
author_sort Vandenberg, Victoria B.
collection PubMed
description Objective: The purpose of this article is to describe the early clinical experience with AWBAT. Methods: Burn patients requiring (1) donor sites or (2) treatment of a superficial burn wound injury were treated. A total of 45 patients with 69 distinct wounds were included. AWBAT(TM)-D was evaluated in donor sites and AWBAT(TM)-S was evaluated in superficial partial-thickness burns. Days to healing, pain, hematoma/seroma formation, and infection were noted. Ease of application, adherence, transparency, and physical adaptability details were collected. Results: Average period to healing of donor sites treated with AWBAT-D (n=22 patients with n=26 wounds) was 11.2 days, σ =1.95, with a range of 8–15 days and a median of 11 days. Pain rating at 24 hours was 1.2, σ =0.43 (n=18) and at 48 hours mean was 1.2, σ =0.46 (n=15). Average period to healing of superficial burns treated with AWBAT-S (n=15 patients with n=18 wounds) was 8.1 days, σ =2.48, with a range of 5–13 days and a median of 7 days. Pain rating at 24 hours was 1.5, σ =0.85 (n=10) and at 48 hours mean was 1.75, σ =0.89 (n=8). There was zero incidence of hematoma/seroma. No infections were seen. Results indicate that AWBAT was easily applied with good initial adherence. It was noted to be transparent, conformant, and pliable. Discussion: Early experience demonstrates that AWBAT performs well on donor sites and superficial partial-thickness burns and delivers the desired attributes of a temporary skin substitute including good adherence, infection control, transparency, adapatability, and pain control.
format Text
id pubmed-2847823
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Open Science Company, LLC
record_format MEDLINE/PubMed
spelling pubmed-28478232010-04-01 AWBAT(TM): Early Clinical Experience Vandenberg, Victoria B. Eplasty Journal Article Objective: The purpose of this article is to describe the early clinical experience with AWBAT. Methods: Burn patients requiring (1) donor sites or (2) treatment of a superficial burn wound injury were treated. A total of 45 patients with 69 distinct wounds were included. AWBAT(TM)-D was evaluated in donor sites and AWBAT(TM)-S was evaluated in superficial partial-thickness burns. Days to healing, pain, hematoma/seroma formation, and infection were noted. Ease of application, adherence, transparency, and physical adaptability details were collected. Results: Average period to healing of donor sites treated with AWBAT-D (n=22 patients with n=26 wounds) was 11.2 days, σ =1.95, with a range of 8–15 days and a median of 11 days. Pain rating at 24 hours was 1.2, σ =0.43 (n=18) and at 48 hours mean was 1.2, σ =0.46 (n=15). Average period to healing of superficial burns treated with AWBAT-S (n=15 patients with n=18 wounds) was 8.1 days, σ =2.48, with a range of 5–13 days and a median of 7 days. Pain rating at 24 hours was 1.5, σ =0.85 (n=10) and at 48 hours mean was 1.75, σ =0.89 (n=8). There was zero incidence of hematoma/seroma. No infections were seen. Results indicate that AWBAT was easily applied with good initial adherence. It was noted to be transparent, conformant, and pliable. Discussion: Early experience demonstrates that AWBAT performs well on donor sites and superficial partial-thickness burns and delivers the desired attributes of a temporary skin substitute including good adherence, infection control, transparency, adapatability, and pain control. Open Science Company, LLC 2010-03-15 /pmc/articles/PMC2847823/ /pubmed/20361005 Text en Copyright © 2010 The Author(s) http://creativecommons.org/licenses/by/2.0/ This is an open-access article whereby the authors retain copyright of the work. The article is distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Journal Article
Vandenberg, Victoria B.
AWBAT(TM): Early Clinical Experience
title AWBAT(TM): Early Clinical Experience
title_full AWBAT(TM): Early Clinical Experience
title_fullStr AWBAT(TM): Early Clinical Experience
title_full_unstemmed AWBAT(TM): Early Clinical Experience
title_short AWBAT(TM): Early Clinical Experience
title_sort awbat(tm): early clinical experience
topic Journal Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847823/
https://www.ncbi.nlm.nih.gov/pubmed/20361005
work_keys_str_mv AT vandenbergvictoriab awbattmearlyclinicalexperience